Table 2.
Correlation Between SNHG22 Expression and Clinicopathologic Characteristics of EOC Patients
| Variables | SNHG22 Expression | P-value | ||
|---|---|---|---|---|
| Total (n=120) | High Expression | Low Expression | ||
| Age (years) | ||||
| ≤60 | 53 | 27 | 26 | 0.94 |
| >60 | 67 | 32 | 35 | |
| Tumor size (cm) | ||||
| ≤5 | 84 | 47 | 37 | 0.06 |
| > 5 | 36 | 16 | 24 | |
| Tumor invasion depth | ||||
| T1-2 | 28 | 12 | 16 | 0.23 |
| T3-4 | 92 | 53 | 39 | |
| Lymph node metastasis | ||||
| N0 | 45 | 25 | 20 | 0.08 |
| N1-2 | 75 | 36 | 39 | |
| Vessel invasion | ||||
| Yes | 69 | 49 | 20 | 0.03 |
| No | 51 | 20 | 31 | |
| TNM stage | ||||
| I–II | 28 | 6 | 22 | <0.01 |
| III–IV | 92 | 51 | 41 | |
| Differentiation | ||||
| High | 38 | 20 | 18 | 0.80 |
| Moderate and low | 82 | 42 | 40 | |
| Smoking status | ||||
| Ever | 46 | 24 | 22 | 0.92 |
| Never | 74 | 36 | 38 | |
| Drinking status | ||||
| Ever | 58 | 28 | 30 | 0.96 |
| Never | 62 | 30 | 32 | |